Logo image
A case series involving young children presenting with accidental ingestion of amphetamine based stimulants
Journal article   Open access   Peer reviewed

A case series involving young children presenting with accidental ingestion of amphetamine based stimulants

Kelly E Wood, Patrick J McCarthy and Matthew D Krasowski
Toxicology reports, Vol.5, pp.1129-1133
2018
DOI: 10.1016/j.toxrep.2018.11.001
PMCID: PMC6258139
PMID: 30510906
url
https://doi.org/10.1016/j.toxrep.2018.11.001View
Published (Version of record) Open Access

Abstract

• Attention Deficity Hyperactivity Disorder (ADHD) affects adults and children. • Stimulant prescribing for ADHD is increasing. • Overdose of amphetamine based stimulants results in a sympathomimetic toxidrome. • Lisdexamfetamine dimesylate is the first prodrug stimulant developed to treat ADHD.
ADHD, attention deficit hyperactivity disorder BPM, beats per minute BMP, basic metabolic panel MDA, methylenedioxyamphetamine A, not applicable MS, liquid chromatography ELISA, enzyme-linked immunosorbent assay L, milliequivalents per liter d-amphetamine, dextroamphetamine tandem mass spectrometry 5-HT, serotonin mass spectrometry MDEA, methylenedioxyethylamphetamine mL, nanogram per milliliter CK, creatinine kinase DSM-V, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition QNS, quantity not sufficient HPLC THC, tetrahydrocannabinol MS, gas chromatography MDMA, methylenedioxymethamphetamine C, Celsius EKG, electrocardiogram FDA, Food and Drug Administration U.S., United States MS, high performance liquid chromatography UDS, urine drug screen ED, emergency department mg, milligram CBC, complete blood count LDX, lisdexamfetamine dimesylate mEq UA, urinalysis AG, anion gap mg, picogram per milligram

Details

Metrics

Logo image